+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Glaucoma Implant Device Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6149918
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Glaucoma Implant Device Market is projected to reach USD 3.71 Billion in 2026. It is expected to continue growing at a CAGR of 8.30%, reaching USD 5.97 Billion by 2032.

Glaucoma Implant Devices: Executive Summary

Glaucoma implant devices are surgical technologies used to lower intraocular pressure when medication, laser treatment, or conventional filtration surgery is insufficient or unsuitable. The market is shaped by the clinical need to preserve vision, improve treatment durability, and address glaucoma in patients with complex disease, prior surgery, or poor adherence to topical therapy. Adoption depends on evidence of safety and effectiveness, surgeon training, reimbursement, regulatory requirements, and access to ophthalmic surgery.

Clinical Complexity Is Reshaping Device Adoption

The landscape is shifting toward more individualized treatment selection. Clinicians increasingly weigh disease severity, ocular anatomy, previous procedures, target pressure, medication burden, and the risk of postoperative complications when choosing between drainage implants and other surgical options. Less invasive approaches are influencing treatment pathways for selected patients, while traditional implants remain important for advanced or refractory glaucoma. Longer-term follow-up, standardized outcomes, and attention to quality of life are becoming more important in technology assessment.

Artificial Intelligence Supports Earlier Detection and Better Follow-Up

Artificial intelligence is contributing to glaucoma care through automated analysis of optic-nerve imaging, retinal nerve-fiber-layer measurements, visual fields, and longitudinal clinical records. These tools may help identify progression, prioritize referrals, and support postoperative monitoring, but they do not replace specialist judgment. For implant-device programs, the most practical near-term applications include risk stratification, detection of pressure-control deterioration, workflow support, and structured analysis of real-world outcomes. Validation across diverse populations, explainability, cybersecurity, and regulatory compliance remain essential.

Regional Dynamics Reflect Uneven Access and Surgical Capacity

North America is characterized by established subspecialty care, broad use of advanced diagnostics, and strong attention to comparative clinical evidence and reimbursement. Europe combines mature ophthalmology networks with varied national procurement and health-technology-assessment processes. Asia-Pacific presents substantial clinical need alongside wide differences in access, with Japan, Australia, South Korea, China, and India representing distinct regulatory, reimbursement, and provider environments. Latin America is influenced by public-private care differences, specialist concentration, and affordability considerations. The Middle East is developing specialized ophthalmic capacity, particularly in major urban centers, while Africa faces significant gaps in screening, referral, surgical access, and postoperative follow-up.

Economic and Policy Groups Reveal Different Adoption Conditions

ASEAN markets generally require adaptable distribution, training, and reimbursement strategies because healthcare capacity and regulatory pathways vary across members. BRICS countries combine large and diverse patient populations with uneven access, domestic manufacturing priorities, and differing public procurement systems. European Union adoption is shaped by coordinated regulatory principles but nationally determined reimbursement and purchasing decisions. G7 systems typically provide stronger specialist infrastructure and evidence-generation capabilities, although cost-effectiveness scrutiny remains significant. GCC countries often combine substantial investment in specialized healthcare with reliance on imported expertise and technologies. NATO membership does not create a unified medical-device market, but countries in this group may share interests in resilient supply chains, clinical preparedness, and secure digital health infrastructure.

Country-Level Priorities Differ Across Mature and Developing Care Systems

Australia and Canada emphasize specialist-led care, evidence-based reimbursement, and service delivery across geographically dispersed populations. The United States has extensive glaucoma subspecialty capacity but faces complex payer, coding, and regulatory requirements. The United Kingdom, France, Germany, Italy, and Spain operate within mature European clinical environments, with procurement and reimbursement shaped by national or regional health systems. China and India combine major clinical need with substantial variation between metropolitan and rural access, while local regulatory and procurement considerations are influential. Japan and South Korea have advanced ophthalmic capabilities and aging populations, with careful attention to clinical evidence and device oversight. Brazil, Mexico, and Russia face regional disparities in specialist access, public-sector purchasing, and continuity of postoperative care.

Prioritize Evidence, Training, Access, and Patient-Centered Outcomes

Industry leaders should develop evidence packages that report sustained pressure control, medication reduction, visual-function preservation, adverse events, reintervention, and patient-reported outcomes. Training programs should address patient selection, implantation technique, complication management, and postoperative surveillance, using experienced centers to support skills transfer. Market access strategies should align with local reimbursement, procurement, and regulatory requirements rather than assume a uniform global pathway. Organizations should also strengthen supply-chain resilience, invest in interoperable data systems, and use artificial intelligence only with robust clinical validation, privacy safeguards, and clinician oversight. Partnerships with hospitals and professional societies can improve referral pathways and longitudinal follow-up.

Methodology Based on Triangulated Clinical and Market Evidence

This executive summary uses a structured qualitative review of the glaucoma implant-device landscape, focusing on clinical use cases, treatment pathways, technology development, regional healthcare conditions, policy environments, and adoption barriers. Findings should be validated through peer-reviewed clinical literature, regulatory documents, reimbursement policies, hospital procurement criteria, professional-society guidance, and interviews with ophthalmologists and health-system stakeholders. Regional, group, and country comparisons are interpreted as directional context; they do not constitute market estimates, forecasts, market shares, or financial sizing.

Durable Adoption Depends on Measurable Clinical Value

Glaucoma implant devices address an important need when pressure reduction remains inadequate or treatment complexity is high. Future progress will depend less on device availability alone and more on demonstrable long-term outcomes, appropriate patient selection, surgeon capability, reliable follow-up, and equitable access. Artificial intelligence can strengthen detection and monitoring when responsibly implemented, while regional and country-specific strategies are necessary to navigate differences in regulation, reimbursement, infrastructure, and clinical practice.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Glaucoma Implant Device Market, by Product Type
7.1. Introduction
7.2. Minimally Invasive
7.2.1. Subconjunctival Stent
7.2.2. Suprachoroidal Shunt
7.2.3. Trabecular Bypass
7.3. Nonvalved
7.3.1. Baerveldt
7.3.2. Molteno
7.4. Valved
8. Glaucoma Implant Device Market, by Glaucoma Type
8.1. Introduction
8.2. Angle Closure
8.3. Open Angle
8.4. Secondary
8.4.1. Neovascular
8.4.2. Traumatic
8.4.3. Uveitic
9. Glaucoma Implant Device Market, by Distribution Channel
9.1. Introduction
9.2. Direct Sales
9.2.1. Government Tender
9.2.2. Private Contract
9.3. Distributor Sales
9.3.1. Retail Partner
9.3.2. Wholesale Distributor
9.4. Online Sales
9.4.1. ECommerce Platform
9.4.2. Manufacturer Portal
10. Glaucoma Implant Device Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Center
10.3. Hospitals
10.4. Ophthalmology Clinic
11. Glaucoma Implant Device Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Glaucoma Implant Device Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Glaucoma Implant Device Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Alcon Inc.
15.2. Allergan plc
15.3. AqueSys, Inc.
15.4. Bausch Health Companies Inc.
15.5. Carl Zeiss Meditec AG
15.6. Glaukos Corporation
15.7. iSTAR Medical SA
15.8. Ivantis, Inc.
15.9. Johnson & Johnson Vision Care, Inc.
15.10. New World Medical, Inc.
15.11. Nova Eye Medical Limited
15.12. Santen Pharmaceutical Co., Ltd.
15.13. Sight Sciences, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Glaucoma Implant Device Market, Years Considered for the Study
FIGURE 2. Global Glaucoma Implant Device Market, Research Design
FIGURE 3. Global Glaucoma Implant Device Market, Research Framework
FIGURE 4. Global Glaucoma Implant Device Market, Data Triangulation
FIGURE 5. Global Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Glaucoma Implant Device Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Glaucoma Implant Device Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Glaucoma Implant Device Market Size, by Glaucoma Type, 2025 vs 2032 (%)
FIGURE 9. Global Glaucoma Implant Device Market Size, by Glaucoma Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Glaucoma Implant Device Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Glaucoma Implant Device Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Glaucoma Implant Device Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Glaucoma Implant Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Glaucoma Implant Device Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Glaucoma Implant Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Glaucoma Implant Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Glaucoma Implant Device Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Glaucoma Implant Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Glaucoma Implant Device Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Glaucoma Implant Device Market Segmentation & Coverage
TABLE 2. Global Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 3. Global Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Minimally Invasive Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Minimally Invasive Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Minimally Invasive Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Subconjunctival Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Subconjunctival Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Subconjunctival Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Suprachoroidal Shunt Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Suprachoroidal Shunt Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Suprachoroidal Shunt Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Trabecular Bypass Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Trabecular Bypass Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Trabecular Bypass Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Nonvalved Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Nonvalved Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Nonvalved Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Baerveldt Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Baerveldt Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Baerveldt Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Molteno Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Molteno Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Molteno Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Valved Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Valved Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Valved Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 29. Global Angle Closure Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Angle Closure Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Angle Closure Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Open Angle Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Open Angle Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Open Angle Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Secondary Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Secondary Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Secondary Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Neovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Neovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Neovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Traumatic Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Traumatic Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Traumatic Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Uveitic Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Uveitic Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Uveitic Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 48. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Government Tender Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Government Tender Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Government Tender Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Private Contract Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Private Contract Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Private Contract Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Distributor Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Distributor Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Distributor Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Retail Partner Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Retail Partner Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Retail Partner Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Wholesale Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Wholesale Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Wholesale Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Online Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Online Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Online Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global ECommerce Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global ECommerce Platform Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global ECommerce Platform Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Manufacturer Portal Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Manufacturer Portal Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Manufacturer Portal Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. Global Ambulatory Surgery Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Ambulatory Surgery Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Ambulatory Surgery Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Ophthalmology Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Ophthalmology Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Ophthalmology Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Glaucoma Implant Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Glaucoma Implant Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. North America Glaucoma Implant Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. North America Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. North America Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 100. North America Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 101. North America Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 102. North America Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 103. North America Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. North America Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 105. North America Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 106. North America Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 107. North America Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Latin America Glaucoma Implant Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Latin America Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. Latin America Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 111. Latin America Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 112. Latin America Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 113. Latin America Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 114. Latin America Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. Latin America Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 116. Latin America Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 117. Latin America Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 118. Latin America Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Europe Glaucoma Implant Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Europe Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. Europe Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 122. Europe Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 123. Europe Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 124. Europe Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 125. Europe Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. Europe Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 127. Europe Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 128. Europe Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 129. Europe Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. Middle East Glaucoma Implant Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Middle East Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. Middle East Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 133. Middle East Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 134. Middle East Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 135. Middle East Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 136. Middle East Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. Middle East Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 138. Middle East Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 139. Middle East Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 140. Middle East Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Africa Glaucoma Implant Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Africa Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. Africa Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 144. Africa Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 145. Africa Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 146. Africa Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 147. Africa Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. Africa Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 149. Africa Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 150. Africa Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 151. Africa Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Global Glaucoma Implant Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. ASEAN Glaucoma Implant Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. ASEAN Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. ASEAN Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 156. ASEAN Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 157. ASEAN Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 158. ASEAN Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 159. ASEAN Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. ASEAN Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 161. ASEAN Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 162. ASEAN Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 163. ASEAN Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. GCC Glaucoma Implant Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. GCC Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. GCC Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 167. GCC Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 168. GCC Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 169. GCC Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 170. GCC Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. GCC Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 172. GCC Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 173. GCC Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 174. GCC Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. European Union Glaucoma Implant Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. European Union Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. European Union Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 178. European Union Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 179. European Union Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 180. European Union Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 181. European Union Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. European Union Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 183. European Union Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 184. European Union Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 185. European Union Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. BRICS Glaucoma Implant Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. BRICS Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. BRICS Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 189. BRICS Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 190. BRICS Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 191. BRICS Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 192. BRICS Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. BRICS Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 194. BRICS Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 195. BRICS Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 196. BRICS Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. G7 Glaucoma Implant Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. G7 Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. G7 Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 200. G7 Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 201. G7 Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 202. G7 Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 203. G7 Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. G7 Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 205. G7 Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 206. G7 Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 207. G7 Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. NATO Glaucoma Implant Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. NATO Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. NATO Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 211. NATO Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 212. NATO Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 213. NATO Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 214. NATO Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. NATO Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 216. NATO Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 217. NATO Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 218. NATO Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Global Glaucoma Implant Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 220. United States Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 221. United States Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. United States Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 223. United States Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 224. United States Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 225. United States Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 226. United States Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 227. United States Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 228. United States Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 229. United States Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 230. United States Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Canada Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 232. Canada Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. Canada Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 234. Canada Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 235. Canada Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 236. Canada Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 237. Canada Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. Canada Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 239. Canada Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 240. Canada Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 241. Canada Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Mexico Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 243. Mexico Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. Mexico Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 245. Mexico Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 246. Mexico Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 247. Mexico Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 248. Mexico Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. Mexico Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 250. Mexico Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 251. Mexico Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 252. Mexico Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Brazil Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 254. Brazil Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. Brazil Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 256. Brazil Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 257. Brazil Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 258. Brazil Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 259. Brazil Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. Brazil Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 261. Brazil Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 262. Brazil Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 263. Brazil Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. United Kingdom Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 265. United Kingdom Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 266. United Kingdom Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 267. United Kingdom Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 268. United Kingdom Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 269. United Kingdom Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 270. United Kingdom Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 271. United Kingdom Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 272. United Kingdom Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 273. United Kingdom Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 274. United Kingdom Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. Germany Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 276. Germany Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. Germany Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 278. Germany Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 279. Germany Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 280. Germany Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 281. Germany Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. Germany Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 283. Germany Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 284. Germany Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 285. Germany Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. France Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 287. France Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 288. France Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 289. France Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 290. France Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 291. France Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 292. France Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 293. France Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 294. France Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 295. France Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 296. France Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. Russia Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 298. Russia Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. Russia Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 300. Russia Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 301. Russia Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 302. Russia Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 303. Russia Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 304. Russia Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 305. Russia Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 306. Russia Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 307. Russia Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Italy Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 309. Italy Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 310. Italy Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 311. Italy Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 312. Italy Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 313. Italy Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 314. Italy Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 315. Italy Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 316. Italy Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 317. Italy Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 318. Italy Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. Spain Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 320. Spain Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 321. Spain Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 322. Spain Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 323. Spain Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 324. Spain Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 325. Spain Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 326. Spain Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 327. Spain Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 328. Spain Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 329. Spain Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 330. China Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 331. China Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 332. China Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 333. China Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 334. China Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 335. China Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 336. China Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 337. China Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 338. China Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 339. China Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 340. China Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 341. India Glaucoma Implant Device Market Size, 2017-2032 (USD Million)
TABLE 342. India Glaucoma Implant Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 343. India Glaucoma Implant Device Market Size, by Minimally Invasive, 2017-2032 (USD Million)
TABLE 344. India Glaucoma Implant Device Market Size, by Nonvalved, 2017-2032 (USD Million)
TABLE 345. India Glaucoma Implant Device Market Size, by Glaucoma Type, 2017-2032 (USD Million)
TABLE 346. India Glaucoma Implant Device Market Size, by Secondary, 2017-2032 (USD Million)
TABLE 347. India Glaucoma Implant Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 348. India Glaucoma Implant Device Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 349. India Glaucoma Implant Device Market Size, by Distributor Sales, 2017-2032 (USD Million)
TABLE 350. India Glaucoma Implant Device Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 351. India Glaucoma Implant Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 352. Japan Glaucoma Implant Device Market Size, 2017-203

Companies Mentioned

  • Alcon Inc.
  • Allergan plc
  • AqueSys, Inc.
  • Bausch Health Companies Inc.
  • Carl Zeiss Meditec AG
  • Glaukos Corporation
  • iSTAR Medical SA
  • Ivantis, Inc.
  • Johnson & Johnson Vision Care, Inc.
  • New World Medical, Inc.
  • Nova Eye Medical Limited
  • Santen Pharmaceutical Co., Ltd.
  • Sight Sciences, Inc.